Eton Pharmaceuticals, Inc.: operating_income
| Value | {"amount": -10321000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | Eton Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bd1ab415-12fb-45c1-937c-e4a06ede18fc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-19-003817Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001710340/operating-income/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bd1ab415-12fb-45c1-937c-e4a06ede18fc
History
- no predecessors — first report